{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T06:43:20Z","timestamp":1785393800342,"version":"3.55.0"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Thelma M\u00e4kikyr\u00f6 Foundation"},{"DOI":"10.13039\/100011935","name":"Pohjois-Suomen Terveydenhuollon Tukis\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011935","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015389","name":"Suomen Onkologiayhdistys","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015389","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015389","name":"Suomen Onkologiayhdistys","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015389","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>This protocol outlines a prospective study aimed at enhancing the diagnosis and monitoring of brain tumors through advanced non-invasive imaging techniques. While magnetic resonance imaging (MRI) is a cornerstone of brain tumor diagnostics, it often lacks the specificity required for definitive diagnosis, which typically relies on invasive tissue sampling. To address this, the study will evaluate advanced MRI techniques\u2014such as perfusion, diffusion, blood-oxygen-level-dependent imaging, magnetic resonance spectroscopy, and amide proton transfer-weighted imaging\u2014 that offer valuable physiological and molecular insights, beyond conventional anatomical imaging. Despite their potential, clinical adoption of these methods remains limited. MRI also plays a central role in treatment response assessment and follow-up, yet conventional anatomical sequences may not detect early physiological changes or differentiate true progression from pseudoprogression. Advanced imaging methods have shown promise in addressing these limitations, and predictive models for recurrence risk could further personalize treatment strategies. In this study, imaging will be performed using a standardized 3T MRI scanner at multiple time points: preoperatively, before radiotherapy, during treatment, and throughout follow-up. This protocol aims to establish a multiparametric imaging framework capable of capturing dynamic physiological and molecular changes in brain tumors. The primary goal is to determine whether combining advanced sequences improves diagnostic accuracy compared to conventional MRI, using histopathology as the reference. Secondary objectives include predicting treatment response, distinguishing true progression from pseudoprogression, and modeling spatial recurrence risk based on quantitative imaging biomarkers. We hypothesize that a multiparametric imaging approach will, enable earlier detection of tumor progression and support more precise, individualized treatment decisions.<\/jats:p>","DOI":"10.1371\/journal.pone.0336387","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T18:24:13Z","timestamp":1763144653000},"page":"e0336387","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Improved brain tumor diagnostics and follow-up with novel magnetic resonance imaging methods: A single center study protocol"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2229-0160","authenticated-orcid":true,"given":"Jesse","family":"Lohela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaisa","family":"Lehti\u00f6","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalle","family":"Inget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakari S.","family":"Karhula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Piironen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang\u00e9lica","family":"Suutari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti","family":"Knuutinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miro","family":"J\u00e4nk\u00e4l\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eveliina","family":"Lammentausta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela K.","family":"Bode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha","family":"Nikkinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niina","family":"Salokorpi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3300-5022","authenticated-orcid":true,"given":"Tuija","family":"Kein\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"issue":"3","key":"pone.0336387.ref001","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41571-020-00447-z","article-title":"EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood","volume":"18","author":"M Weller","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"pone.0336387.ref002","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10143-019-01234-w","article-title":"Complications after frame-based stereotactic brain biopsy: a systematic review","volume":"44","author":"M Riche","year":"2021","journal-title":"Neurosurg Rev"},{"issue":"4","key":"pone.0336387.ref003","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1200\/JCO.21.02036","article-title":"Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline","volume":"40","author":"NA Mohile","year":"2022","journal-title":"J Clin Oncol"},{"issue":"3","key":"pone.0336387.ref004","article-title":"Treatment of Adult Gliomas: A Current Update","volume":"15","author":"JH Lee","year":"2022","journal-title":"Brain Neurorehabil"},{"key":"pone.0336387.ref005","doi-asserted-by":"crossref","first-page":"108409","DOI":"10.1016\/j.clineuro.2024.108409","article-title":"Predicting response to chemotherapy in brain tumor patients based on MRI features","volume":"244","author":"R Tariq","year":"2024","journal-title":"Clin Neurol Neurosurg"},{"key":"pone.0336387.ref006","doi-asserted-by":"crossref","DOI":"10.1016\/j.wneu.2020.04.134","article-title":"The Fluctuations of Blood Oxygen Level-Dependent Signals as a Method of Brain Tumor Characterization: A Preliminary Report","volume":"142","author":"H Metwali","year":"2020","journal-title":"World Neurosurg"},{"issue":"2","key":"pone.0336387.ref007","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s11060-013-1210-7","article-title":"MR-based hypoxia measures in human glioma","volume":"115","author":"V T\u00f3th","year":"2013","journal-title":"J Neurooncol"},{"key":"pone.0336387.ref008","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3389\/fnagi.2017.00271","article-title":"Analysis of DTI-Derived Tensor Metrics in Differential Diagnosis between Low-grade and High-grade Gliomas","volume":"9","author":"L Jiang","year":"2017","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"pone.0336387.ref009","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3174\/ajnr.A2333","article-title":"Differentiation between glioblastomas, solitary brain metastases, and primary cerebral lymphomas using diffusion tensor and dynamic susceptibility contrast-enhanced MR imaging","volume":"32","author":"S Wang","year":"2011","journal-title":"AJNR Am J Neuroradiol"},{"key":"pone.0336387.ref010","doi-asserted-by":"crossref","first-page":"109694","DOI":"10.1016\/j.radonc.2023.109694","article-title":"CEST imaging of the APT and ssMT predict the overall survival of patients with glioma at the first follow-up after completion of radiotherapy at 3T","volume":"184","author":"N von Knebel Doeberitz","year":"2023","journal-title":"Radiother Oncol"},{"issue":"1","key":"pone.0336387.ref011","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00330-017-4962-1","article-title":"Amide proton transfer imaging for differentiation of benign and atypical meningiomas","volume":"28","author":"B Joo","year":"2018","journal-title":"Eur Radiol"},{"issue":"1","key":"pone.0336387.ref012","doi-asserted-by":"crossref","first-page":"11223","DOI":"10.1038\/s41598-021-90841-z","article-title":"Correlation between amide proton transfer-related signal intensity and diffusion and perfusion magnetic resonance imaging parameters in high-grade glioma","volume":"11","author":"M Nakajo","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"pone.0336387.ref013","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1148\/radiol.2020191037","article-title":"Comparison of Multivendor Single-Voxel MR Spectroscopy Data Acquired in Healthy Brain at 26 Sites","volume":"295","author":"M Pova\u017ean","year":"2020","journal-title":"Radiology"},{"key":"pone.0336387.ref014","doi-asserted-by":"crossref","first-page":"1130188","DOI":"10.3389\/fpsyg.2023.1130188","article-title":"Comparison of different approaches to manage multi-site magnetic resonance spectroscopy clinical data analysis","volume":"14","author":"PL La","year":"2023","journal-title":"Front Psychol"},{"issue":"3","key":"pone.0336387.ref015","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/neuros\/nyx103","article-title":"Current Clinical Brain Tumor Imaging","volume":"81","author":"JE Villanueva-Meyer","year":"2017","journal-title":"Neurosurgery"},{"issue":"1","key":"pone.0336387.ref016","doi-asserted-by":"crossref","first-page":"8","DOI":"10.14791\/btrt.2015.3.1.8","article-title":"Modern brain tumor imaging","volume":"3","author":"MC Mabray","year":"2015","journal-title":"Brain Tumor Res Treat"},{"issue":"8","key":"pone.0336387.ref017","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1007\/s00330-018-5314-5","article-title":"Glioma imaging in Europe: A survey of 220 centres and recommendations for best clinical practice","volume":"28","author":"SC Thust","year":"2018","journal-title":"Eur Radiol"},{"issue":"9","key":"pone.0336387.ref018","first-page":"1188","article-title":"Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials","volume":"17","author":"BM Ellingson","year":"2015","journal-title":"Neuro Oncol"},{"issue":"21","key":"pone.0336387.ref019","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1200\/JCO.2017.72.7511","article-title":"Response Assessment in Neuro-Oncology Clinical Trials","volume":"35","author":"PY Wen","year":"2017","journal-title":"J Clin Oncol"},{"issue":"33","key":"pone.0336387.ref020","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1200\/JCO.23.01059","article-title":"RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults","volume":"41","author":"PY Wen","year":"2023","journal-title":"J Clin Oncol"},{"issue":"1","key":"pone.0336387.ref021","doi-asserted-by":"crossref","first-page":"7632","DOI":"10.1038\/s41598-021-84331-5","article-title":"Assessment of tumor hypoxia and perfusion in recurrent glioblastoma following bevacizumab failure using MRI and 18F-FMISO PET","volume":"11","author":"S Huang","year":"2021","journal-title":"Sci Rep"},{"issue":"6","key":"pone.0336387.ref022","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/CCO.0000000000000793","article-title":"Current emerging MRI tools for radionecrosis and pseudoprogression diagnosis","volume":"33","author":"L Nichelli","year":"2021","journal-title":"Curr Opin Oncol"},{"issue":"52","key":"pone.0336387.ref023","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000023766","article-title":"Evaluation of perfusion MRI value for tumor progression assessment after glioma radiotherapy: A systematic review and meta-analysis","volume":"99","author":"L Wang","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"pone.0336387.ref024","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.mric.2015.09.001","article-title":"Multiparametric MR Imaging in the Assessment of Brain Tumors","volume":"24","author":"M Kimura","year":"2016","journal-title":"Magn Reson Imaging Clin N Am"},{"issue":"8","key":"pone.0336387.ref025","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.1002\/mp.16256","article-title":"Multi-parametric MRI for radiotherapy simulation","volume":"50","author":"T Li","year":"2023","journal-title":"Med Phys"},{"issue":"1","key":"pone.0336387.ref026","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3390\/pharmaceutics16010101","article-title":"Preclinical Application of CEST MRI to Detect Early and Regional Tumor Response to Local Brain Tumor Treatment","volume":"16","author":"S-W Park","year":"2024","journal-title":"Pharmaceutics"},{"issue":"2","key":"pone.0336387.ref027","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11060-020-03661-y","article-title":"Quantitative CEST and MT at 1.5T for monitoring treatment response in glioblastoma: early and late tumor progression during chemoradiation","volume":"151","author":"RW Chan","year":"2021","journal-title":"J Neurooncol"},{"issue":"11","key":"pone.0336387.ref028","doi-asserted-by":"crossref","first-page":"5889","DOI":"10.1118\/1.4963812","article-title":"Stratification of pseudoprogression and true progression of glioblastoma multiform based on longitudinal diffusion tensor imaging without segmentation","volume":"43","author":"X Qian","year":"2016","journal-title":"Med Phys"},{"issue":"4","key":"pone.0336387.ref029","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/mrm.29746","article-title":"Semi-solid MT and APTw CEST-MRI predict clinical outcome of patients with glioma early after radiotherapy","volume":"90","author":"F Kroh","year":"2023","journal-title":"Magn Reson Med"},{"issue":"1","key":"pone.0336387.ref030","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3174\/ajnr.A4474","article-title":"Differentiating Tumor Progression from Pseudoprogression in Patients with Glioblastomas Using Diffusion Tensor Imaging and Dynamic Susceptibility Contrast MRI","volume":"37","author":"S Wang","year":"2016","journal-title":"AJNR Am J Neuroradiol"},{"key":"pone.0336387.ref031","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1200\/JCO.2017.35.15_suppl.2016","article-title":"Multicenter study to demonstrate radiomic texture features derived from MR perfusion images of pseudoprogression compared to true progression in glioblastoma patients","volume":"35","author":"N Elshafeey","year":"2017","journal-title":"J Clin Oncol"},{"issue":"1","key":"pone.0336387.ref032","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12880-017-0183-y","article-title":"Combination of IVIM-DWI and 3D-ASL for differentiating true progression from pseudoprogression of Glioblastoma multiforme after concurrent chemoradiotherapy: study protocol of a prospective diagnostic trial","volume":"17","author":"Z-C Liu","year":"2017","journal-title":"BMC Med Imaging"},{"issue":"1","key":"pone.0336387.ref033","article-title":"Magnetic resonance spectroscopy outperforms perfusion in distinguishing between pseudoprogression and disease progression in patients with glioblastoma","volume":"4","author":"ME El-Abtah","year":"2022","journal-title":"Neurooncol Adv"},{"issue":"4","key":"pone.0336387.ref034","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1177\/0284185112474916","article-title":"Pseudoprogression in patients with glioblastoma: added value of arterial spin labeling to dynamic susceptibility contrast perfusion MR imaging","volume":"54","author":"YJ Choi","year":"2013","journal-title":"Acta Radiol"},{"issue":"4","key":"pone.0336387.ref035","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1093\/brain\/awac360","article-title":"Structural connectome quantifies tumour invasion and predicts survival in glioblastoma patients","volume":"146","author":"Y Wei","year":"2023","journal-title":"Brain"},{"issue":"3","key":"pone.0336387.ref036","doi-asserted-by":"crossref","first-page":"568","DOI":"10.3390\/cancers12030568","article-title":"Detection of Glioblastoma Subclinical Recurrence Using Serial Diffusion Tensor Imaging","volume":"12","author":"Y Jin","year":"2020","journal-title":"Cancers (Basel)"},{"key":"pone.0336387.ref037","doi-asserted-by":"crossref","first-page":"123382","DOI":"10.1016\/j.wneu.2024.10.111","article-title":"DTI Analysis of the Peritumoral Zone of Diffuse Low-grade Gliomas in Progressing Patients","volume":"194","author":"D Chiche","year":"2025","journal-title":"World Neurosurg"},{"key":"pone.0336387.ref038","article-title":"SPIRIT 2025 statement: updated guideline for protocols of randomised trials","volume":"389","author":"A-W Chan","year":"2025","journal-title":"BMJ"},{"key":"pone.0336387.ref039","doi-asserted-by":"crossref","first-page":"117164","DOI":"10.1016\/j.neuroimage.2020.117164","article-title":"Sample size evolution in neuroimaging research: An evaluation of highly-cited studies (1990-2012) and of latest practices (2017-2018) in high-impact journals","volume":"221","author":"D Szucs","year":"2020","journal-title":"Neuroimage"},{"issue":"5","key":"pone.0336387.ref040","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1177\/1073858415595004","article-title":"Regional Homogeneity: A Multimodal, Multiscale Neuroimaging Marker of the Human Connectome","volume":"22","author":"L Jiang","year":"2016","journal-title":"Neuroscientist"},{"issue":"1457","key":"pone.0336387.ref041","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1098\/rstb.2005.1634","article-title":"Investigations into resting-state connectivity using independent component analysis","volume":"360","author":"CF Beckmann","year":"2005","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"pone.0336387.ref042","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1053-8119(03)00097-1","article-title":"Independent component analysis of nondeterministic fMRI signal sources","volume":"19","author":"V Kiviniemi","year":"2003","journal-title":"Neuroimage"},{"issue":"1","key":"pone.0336387.ref043","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/s41598-017-18453-0","article-title":"Tumor Tissue Detection using Blood-Oxygen-Level-Dependent Functional MRI based on Independent Component Analysis","volume":"8","author":"H Huang","year":"2018","journal-title":"Sci Rep"},{"key":"pone.0336387.ref044","doi-asserted-by":"crossref","first-page":"109900","DOI":"10.1016\/j.ejrad.2021.109900","article-title":"Advanced MRI assessment of non-enhancing peritumoral signal abnormality in brain lesions","volume":"143","author":"T Mart\u00edn-Noguerol","year":"2021","journal-title":"Eur J Radiol"},{"issue":"1","key":"pone.0336387.ref045","doi-asserted-by":"crossref","first-page":"118","DOI":"10.18383\/j.tom.2018.00035","article-title":"Developing a Pipeline for Multiparametric MRI-Guided Radiation Therapy: Initial Results from a Phase II Clinical Trial in Newly Diagnosed Glioblastoma","volume":"5","author":"MM Kim","year":"2019","journal-title":"Tomography"},{"issue":"3","key":"pone.0336387.ref046","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.ijrobp.2021.01.033","article-title":"A Phase 2 Study of Dose-intensified Chemoradiation Using Biologically Based Target Volume Definition in Patients With Newly Diagnosed Glioblastoma","volume":"110","author":"MM Kim","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"pone.0336387.ref047","doi-asserted-by":"crossref","DOI":"10.1088\/0031-9155\/61\/5\/R32","article-title":"Motion correction in MRI of the brain","volume":"61","author":"F Godenschweger","year":"2016","journal-title":"Phys Med Biol"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0336387","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T18:24:19Z","timestamp":1763144659000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0336387"}},"subtitle":[],"editor":[{"given":"Michael C","family":"Burger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":47,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0336387","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,14]]}}}